Global Cancer Tumor Profiling Market, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancer), Biomarker Type (Genomic Biomarker, Protein Biomarker), Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), Technique (Genomics, Proteomics, Metabolomics, Epigenetics), Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The cancer tumor profiling market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 12.25% in the forecast period of 2021 to 2028 and is expected to reach USD 3,951.34 million by 2028. The increase in prevalence of cancer among population across the globe and the increase in biomarkers adoption in tumor profiling are factors escalating the growth of cancer tumor profiling market.
Cancer is generally differentiated as uncontrolled cell growth which could be fatal. Environmental reasons mostly cause the altering of gene encoding which triggers cell regulation. The cell mutation leads to abnormal cell growth which affects the neighboring cells and organs. Cancer or tumor profiling refers to a diagnostic test which offers genetic information regarding the cancer or tumor present in an individual’s body. This diagnostic test assists in determining the correct course of action, identifying the stage of cancer or and predicting the reoccurrence of the cancer or tumor. It also helps in determining the specific therapeutics for the patient.
The increase in the rate of cancer or tumor cases among people globally and the growing adoption of cancer profiling methods by oncologists are the major factors driving the cancer tumor profiling market. The rise in investment in the research and development activities to enhance the overall course of diagnosis and treatment of cancer and the increasing technological advancement in the field of cancer/tumor profiling accelerate the cancer tumor profiling market growth. The increase in utilization of cancer biomarkers for diagnosing cancer/tumor and the growing pressure on the healthcare sector to provide effective treatment options for the condition also influence the cancer tumor profiling market. Additionally, rise in funds by profit and non-profit organizations for the treatment and diagnosis of the condition and government support positively affect the cancer tumor profiling market. Furthermore, the rise in need for point-of-care diagnostics, launch of new products and the surging demand for personalized medicine extend profitable opportunities to the cancer tumor profiling market players in the forecast period of 2021 to 2028.
On the other hand, high capital investment, high price of the procedure and concerns regarding the technical issues with sample collection and storage are expected to obstruct the cancer tumor profiling market growth. Poor regulatory norms and reimbursement scenario and low discovery-to-approval ratio are projected to challenge the cancer tumor profiling market in the forecast period of 2021-2028.
This cancer tumor profiling market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cancer tumor profiling market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Cancer Tumor Profiling Market Scope and Market Size
The cancer tumor profiling market is segmented on the basis of cancer type, biomarker type, technology, technique and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of cancer type, the cancer tumor profiling market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma cancer and other cancer.
- On the basis of biomarker type, the cancer tumor profiling market is segmented into genomic biomarker and protein biomarker.
- On the basis of technology, the cancer tumor profiling market is segmented into immunoassays, next-generation sequencing, polymerase chain reaction, mass spectrometry, in-situ hybridization, microarrays and others.
- On the basis of technique, the cancer tumor profiling market is segmented into genomics, proteomics, metabolomics and epigenetics.
- On the basis of application, the cancer tumor profiling market is segmented into research, biomarker discovery, personalized medicine, clinical application, diagnostics, prognostics, screening and treatment and monitoring.
Global Cancer Tumor Profiling Market Country Level Analysis
Global cancer tumor profiling market is analyzed and market size insights and trends are provided by country, cancer type, biomarker type, technology, technique and application as referenced above.
The countries covered in the cancer tumor profiling market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the cancer tumor profiling market because of the increasing number of cancer/tumor patients, presence of leading players, rise in oncology research activities to novel therapy and advanced technologies and their growing adoption. Asia-Pacific is estimated to grow in the forecast period of 2021-2028 due to the massive population, availability of massive untapped markets and low penetration rate in the region.
The country section of the cancer tumor profiling market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The cancer tumor profiling market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cancer tumor profiling market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cancer tumor profiling market. The data is available for historic period 2010-2019.
Competitive Landscape and Cancer Tumor Profiling Market Share Analysis
The cancer tumor profiling market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cancer tumor profiling market.
The major players covered in the cancer tumor profiling market report are Illumina, Inc., QIAGEN, NeoGenomics Laboratories, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Helomics Corp., Caris Life Sciences, NanoString Technologies, Inc., Ribomed, Guardant Health, FOUNDATION MEDICINE, INC, F. Hoffmann-La Roche Ltd, GenScript, Tempus, histogenex, Hologic, Inc., Boreal Genomics Inc., Perthera, Inc., Agendia, OmniSeq Corporation, Personal Genome Diagnostics Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Cancer Tumor Profiling Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.